GSSGENETIC SIGNATURES LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 21 Aug 2026, 19:26 | Commercial Testing Commences at Hvidovre Hospital in Denmark | Company Update | — | 11001 | |
| 24 July 2026, 00:11 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 3 July 2026, 03:13 | Becoming a substantial holder from BDX | Substantial Holders | — | 02001 | |
| 3 July 2026, 00:41 | GSS responds to the BCAL Diagnostics Announcement | Company Administration | MS | 12008 | |
| 2 July 2026, 20:04 | BDX: BCAL to Acquire Shares in Genetic Signatures | Other | MS | — | |
| 1 July 2026, 22:20 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 19 June 2026, 18:58 | Change of Company Secretary | Company Administration | — | 12007 | |
| 19 June 2026, 02:55 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 16 June 2026, 21:24 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 10 June 2026, 18:24 | Investor Presentation | Presentations | — | 03026 | |
| 9 June 2026, 18:29 | Investor Webinar Notification | Presentations | — | 14014 | |
| 8 May 2026, 18:17 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 8 May 2026, 18:17 | Board Reorganisation | Company Administration | — | 12008 | |
| 29 Apr 2026, 20:04 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 29 Apr 2026, 18:22 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 23 Apr 2026, 00:47 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 17 Apr 2026, 23:31 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 17 Apr 2026, 23:19 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 16 Apr 2026, 02:37 | Danish Supply Agreement - Additional Information | Company Update | MS | 11001 | |
| 15 Apr 2026, 23:59 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 15 Apr 2026, 18:22 | Genetic Signatures Signs Danish Supply Agreement | Company Update | MS | 11001 | |
| 30 Mar 2026, 20:08 | Genetic Signatures Organisational Restructure | Company Administration | MS | 12008 | |
| 30 Mar 2026, 19:23 | Notification of cessation of securities - GSS | Other | — | 06027 | |
| 18 Mar 2026, 02:49 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 17 Mar 2026, 04:12 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 13 Mar 2026, 01:24 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 11 Mar 2026, 04:53 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 26 Feb 2026, 19:20 | 1H FY26 Results Presentation | Financial Results | MS | 03004, 03026 | |
| 26 Feb 2026, 19:20 | 1H FY26 Results Release | Financial Results | MS | 03004 | |
| 26 Feb 2026, 19:20 | 1H FY26 Appendix 4D and Half Year Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 19 Feb 2026, 00:51 | 1H FY26 Results and Investor Webinar Notification | Presentations | — | 03027, 14014 | |
| 11 Feb 2026, 02:04 | Notification of cessation of securities - GSS | Other | — | 06027 | |
| 6 Feb 2026, 19:20 | GSS Appoints Anne Lockwood as Interim Managing Director | Company Administration | MS | 12008, 12019 | |
| 2 Feb 2026, 20:20 | Genetic Signatures Appoints Maria Halasz as CEO | Other | MS | 12019 | |
| 20 Jan 2026, 19:20 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 15 Dec 2025, 20:27 | Leadership Change at Genetic Signatures Limited | Other | MS | 12019 | |
| 28 Nov 2025, 01:48 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 25 Nov 2025, 06:11 | Change of Director's Interest Notices | Director Interests | — | 02009 | |
| 25 Nov 2025, 06:05 | Notification regarding unquoted securities - GSS | Other | — | 06021 | |
| 22 Nov 2025, 02:34 | Notification of cessation of securities - GSS | Other | — | 06027 | |
| 17 Nov 2025, 21:59 | Results of 2025 Annual General Meeting | Meetings & Governance | — | 08003 | |
| 17 Nov 2025, 19:26 | 2025 Annual General Meeting Chair Address & Presentation | Presentations | MS | 03026, 15002 | |
| 17 Nov 2025, 19:26 | $4.4m R&D Tax Incentive Received | Company Administration | MS | 12008 | |
| 11 Nov 2025, 19:21 | Resignation of Chief Financial Officer | Company Administration | — | 12007, 12008 | |
| 7 Nov 2025, 19:44 | Notification regarding unquoted securities - GSS | Other | — | 06021 | |
| 7 Nov 2025, 19:41 | Chief Executive Officer Remuneration Update | Company Administration | — | 12008 | |
| 21 Oct 2025, 19:31 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 16 Oct 2025, 19:44 | 2025 Notice of Annual General Meeting | Meetings & Governance | — | 08001, 08004, 16002 | |
| 27 Sept 2025, 00:10 | Notification of cessation of securities - GSS | Other | — | 06027 | |
| 29 Aug 2025, 02:44 | Change in substantial holding | Substantial Holders | — | 02002 |
1–50 of 56
1 / 2